2026 OH ACC Spring Summit

Target Audience

This activity is designed for an audience of physicians, physician associates, nurses and pharmacists.

Learning Objectives

Session 1 – Cardiogenetics: NICM / Inherited Arrhythmias 

  • Identify clinical features that warrant suspicion for inherited cardiomyopathies or arrhythmia syndromes and describe the appropriate indications, logistics, and patient referral pathways for genetic testing. 

Session 2 – Advancing Practice 

  • Evaluate emerging applications of artificial intelligence and novel imaging modalities and discuss their potential to improve diagnostic accuracy and clinical workflow in cardiovascular practice. 

Session 3 – Pericarditis 

  • Apply updated diagnostic criteria for pericarditis and incorporate current evidence-based treatment strategies, including newer therapeutic options, into the management of patients with acute and recurrent pericarditis. 

Session 4 – Innovative Practice 

  • Assess the safety and feasibility of outpatient sotalol initiation and summarize the clinical implications of key cardiovascular trials from 2025, including REBOOT, RHEIA, VESALIUSCV, and ALONE-AF. 

62nd Annual Carl J. Wiggers Memorial Lecture – GLP-1s 

  • Articulate the multifaceted cardiovascular effects of GLP-1 receptor agonists and integrate current evidence regarding their cardiometabolic benefits and risks into shared decision-making with patients. 
Course summary
Available credit: 
  • 4.75 AAPA Category 1 CME
  • 4.75 ABIM Medical Knowledge
  • 4.75 ACPE Pharmacist
  • 4.75 AMA PRA Category 1 Credit™
  • 4.75 ANCC

     

     

     

  • 4.75 Attendance
Course opens: 
04/18/2026
Course expires: 
12/31/2026
Cost:
$0.00
Rating: 
0
April 18, 2026 in Warrensville Heights, OH
United States

All of the relevant financial relationships listed for these individuals have been mitigated.

Disclosures
None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product 
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer 
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.

Reviewer(s)

Dorothy Caputo, MA BSN RN

has no relevant financial relationships to disclose at this time.

Dorothy Duffy, RPh

has no relevant financial relationships to disclose at this time.

Rebecca Lakofsky, BSN, RN

has no relevant financial relationships to disclose at this time.
Speaker, Instructor, Faculty(s)

Ashish Aneja, MD FACC FASE FAHA FSCMR

has a financial relationship (Advisor) with Bristol Myers Squibb;.
has a financial relationship (Advisor) with Medtronic;.

Kelly Bartsch, PharmD, BCPS, CLS, AACC

has no relevant financial relationships to disclose at this time.

Marla Bashour, MD

has no relevant financial relationships to disclose at this time.

Naba Farooqui

has no relevant financial relationships to disclose at this time.

Michael Glidden, MD, PhD

has no relevant financial relationships to disclose at this time.

allan klein, Allan L.Klein MD,FRCP(C), FACC, FAHA, FASE, FESC Professor of Medicine at Lerner College of Medicine of Case Western University Director, Center for the Diagnosis and Treatment of Pericardial Diseases Section of Cardiovascular Imaging Department of Cardi

has a financial relationship (Researcher) with zydus;.
has a financial relationship (Researcher) with Kiniksa;.
has a financial relationship (Researcher) with cardiol therapeutics;.
has a financial relationship (Researcher) with Ventyx;.

Megan Labreck, PharmD, BCPS

has no relevant financial relationships to disclose at this time.

Emily Massiello

has no relevant financial relationships to disclose at this time.

Darren McGuire

has a financial relationship (Researcher) with Amgen;.
has a financial relationship (Consultant) with Lilly USA;.
has a financial relationship (Consultant) with Boehringer Ingelheim;.
has a financial relationship (Researcher) with Kailera;.
has a financial relationship (Researcher) with Pfizer;.
has a financial relationship (Researcher) with Novartis;.
has a financial relationship (Consultant) with Novo Nordisk;.
has a financial relationship (Researcher) with Metsera;.
has a financial relationship (Researcher) with New Amsterdam;.
has a financial relationship (Researcher) with Boehringer Ingelheim;.
has a financial relationship (Researcher) with Pfizer;.
has a financial relationship (Researcher) with Novo Nordisk;.
has a financial relationship (Consultant) with Lexicon;.
has a financial relationship (Consultant) with Amgen;.
has a financial relationship (Consultant) with Neurotronic;.
has a financial relationship (Consultant) with Kailera;.
has a financial relationship (Consultant) with Alveus;.
has a financial relationship (Consultant) with Zealand;.
has a financial relationship (Consultant) with Metsera;.
has a financial relationship (Consultant) with Novartis;.
has a financial relationship (Consultant) with F. Hoffman La Roche;.
has a financial relationship (Researcher) with Lilly USA;.

Paul Moodispaw, MD, FACC

has no relevant financial relationships to disclose at this time.

Rocio Moran

has a financial relationship (Executive role) with Pediavascular;.

Thomas O'Neill IV, MD/PhD

has no relevant financial relationships to disclose at this time.

Andres Schuster, MD, FACP, FACC, FASE

has a financial relationship (Consultant) with Ultromics;.

Marguerite Shanahan, MBA, BSN, RN

has no relevant financial relationships to disclose at this time.

Aisha Siraj, M.D

has no relevant financial relationships to disclose at this time.

Gabriel Tensol Rodrigues Pereira

has no relevant financial relationships to disclose at this time.

Phuong Uyen Vo, DO, MPH, MSEd

has no relevant financial relationships to disclose at this time.

Tom Kai Ming Wang, MBChB, MD

has no relevant financial relationships to disclose at this time.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Ohio Chapter, American College of Cardiology. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

This activity was planned by and for the healthcare team, and learners will receive 4.75 Interprofessional Continuing Education (IPCE) credit for learning and change.

 

 

Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 4.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 

Pharmacists
AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 4.75 contact hours.

 

Nursing
Credit being awarded: 4.75 ANCC contact hours

 

Physician Associates
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Available Credit

  • 4.75 AAPA Category 1 CME
  • 4.75 ABIM Medical Knowledge
  • 4.75 ACPE Pharmacist
  • 4.75 AMA PRA Category 1 Credit™
  • 4.75 ANCC

     

     

     

  • 4.75 Attendance

Price

Cost:
$0.00
Please login or register to take this course.